Contact
Please use this form to send email to PR contact of this press release:
BioAegis Therapeutics and TH Chan Harvard School of Public Health Awarded 3-Year $2.8MM NIH Grant to Study Plasma Gelsolin Immunotherapy to Limit Antibiotic-Resistant Pneumonia
TO: